Recruiting Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy NCT07000084 Conditions Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Fairbanks Memorial Hospital — Fairbanks, Alaska, United States Banner MD Anderson Cancer Center — Gilbert, Arizona, United States Mayo Clinic Hospital in Arizona — Phoenix, Arizona, United States View all 58 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer NCT06733363 Conditions Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more Locations Roswell Park Comprehensive Cancer Center — Buffalo, New York, United States View Trial Details
Recruiting PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer NCT06173349 Conditions Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more Locations University of California Davis Comprehensive Cancer Center — Sacramento, California, United States View Trial Details
